{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T22:19:45Z","timestamp":1774736385917,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Suspected cerebral edema diabetic ketoacidosis (SCEDKA) is more common than perceived with symptoms including altered mentation, headache with vomiting, depressed Glasgow coma scale (GCS), abnormal motor or verbal responses, combativeness, and neurological depression. Suspected cerebral edema diabetic ketoacidosis has been associated with initial diabetic ketoacidosis (DKA) presentation and at start of DKA therapy.<\/jats:p>\n            <jats:p>Cerebral oximetry (bihemispheric regional cerebral oxygen saturation [r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub>] and cerebral blood volume index [CBVI]) can detect increased intracranial pressure (ICP)\u2013induced altered bihemispheric cerebral physiology (r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub>) (<jats:italic toggle=\"yes\">Crit Care Med<\/jats:italic> 2006;34:2217\u20132223, <jats:italic toggle=\"yes\">J Pediatr<\/jats:italic> 2013;163: 1111\u20131116, <jats:italic toggle=\"yes\">Curr Med Chem<\/jats:italic> 2009;16:94\u2013112, <jats:italic toggle=\"yes\">Diabetologia<\/jats:italic> 1985;28:739\u2013742, <jats:italic toggle=\"yes\">Pediatr Crit Care Med<\/jats:italic> 2013;14:694\u2013700). In pediatrics, r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> of less than 60% or r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> of greater than 85% reflects increased ICP and cerebral edema (<jats:italic toggle=\"yes\">Crit Care Med<\/jats:italic> 2006;34:2217\u20132223, <jats:italic toggle=\"yes\">J Pediatr<\/jats:italic> 2013;163: 1111\u20131116, <jats:italic toggle=\"yes\">Curr Med Chem<\/jats:italic> 2009;16:94\u2013112, <jats:italic toggle=\"yes\">Diabetologia<\/jats:italic> 1985;28:739\u2013742, <jats:italic toggle=\"yes\">Pediatr Crit Care Med<\/jats:italic> 2013;14:694\u2013700). Cerebral oximetry can detect increased ICP\u2013induced altered bihemispheric cerebral physiology (r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub>, CBVI) and cerebral physiological changes (r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub>, CBVI changes) during therapeutic mechanical cerebral spinal fluid removal to decrease increased ICP (<jats:italic toggle=\"yes\">Crit Care Med<\/jats:italic> 2006;34:2217\u20132223, <jats:italic toggle=\"yes\">J Pediatr<\/jats:italic> 2013;163: 1111\u20131116, <jats:italic toggle=\"yes\">Curr Med Chem<\/jats:italic> 2009;16:94\u2013112, <jats:italic toggle=\"yes\">Diabetologia<\/jats:italic> 1985;28:739\u2013742, <jats:italic toggle=\"yes\">Pediatr Crit Care Med<\/jats:italic> 2013;14:694\u2013700).<\/jats:p>\n            <jats:p>In the pediatric intensive care units, SCEDKA patients with nonbihemispheric cerebral oximetry showed an initial r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> of greater than 90%. Bihemispheric r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> with CBVI in SCEDKA patients has the potential to detect the abnormal cerebral physiology and disruptive autoregulation while detecting 3% hypertonic saline solution (HTS) effects on the SCEDKA altered cerebral physiology (r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub>).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The purposes of this study were to analyze and compare 3% HTS effect on bihemispheric rcSO2 readings, neurological and biochemical parameters in SCEDKA with 3% HTS infusion to non-SCEDKA patients in pediatric emergency department (PED).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>An observational retrospective comparative analysis study of bihemispheric rcSO2 readings, neurological and biochemical parameters in 2 groups of PED DKA patients were performed: PED DKA patients with SCEDKA +3% HTS infusions versus non-SCEDKA without 3% HTS infusions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>From 2008 to 2013, of the 1899 PED DKA patients, 60 SCEDKA patients received 3% HTS (5 mL\/kg via peripheral intravenous) infusion (median age of 5 years [range, 3.7\u20137 years]), with 42 new DKA insulin dependent diabetes mellitus onset. Suspected cerebral edema diabetic ketoacidosis patients had GCS of 11 (range, 11\u201312), with consistent SCEDKA signs and symptoms (severe headaches with vomiting, confusion, blurred vision, altered speech, lethargy, and combativeness). Suspected cerebral edema diabetic ketoacidosis patients' initial (0\u20135 minutes) left r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> readings were 91.4% (range, 88.4%\u201394.1%) and right was 90.3% (range, 88.6%\u201394.1%) compared with non-SCEDKA patients' left r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> readings of 73.2% (range, 69.7%\u201377.8%) and right of 73.2% (range, 67.6%\u201377%) (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). The r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> monitoring time before 3% HTS infusion was 54.9 minutes (range, 48.3\u201366.8 minutes) with 3% HTS time effect change: pre\u20133% HTS (54.9 minutes [range, 48.3\u201366.8 minutes]). Before 3% HTS infusion, the left r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> readings were 90.0% (range, 89%\u201395%) and right was 91% (range, 86%\u201395%). The 30 to 45 minutes post\u20133% HTS showed that left was 64% (range, 62%\u201369%) and right was 65.4% (range, 63%\u201370%) (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> \u0394 change for post\u20133% HTS (0\u201320 minutes) to pre\u20133% HTS was as follows: left, \u221226.58 (\u221229.5 to \u221223.7) (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001); right, \u221225.2 (\u221227.7 to \u221222.6) (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). Post\u20133% HTS GCS (14,15) and biochemistry compared with pre\u20133% HTS infusions all improved (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In PED SCEDKA patients, the pre\u20133% HTS bihemispheric r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> readings were greater than 90% and had lower GCS than non-SCEDKA patients. The post\u20133% HTS infusion r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> readings showed within minutes a substantial reduction compared with non-SCEDKA patients, with no complications. Changes in r<jats:sub>c<\/jats:sub>SO<jats:sub>2<\/jats:sub> readings after 3% HTS correlated with improved SCEDKA indicators (improved mental status, headache, and GCS) without any complications. We showed that cerebral oximetry in PED SCEDKA patients has shown an initial bihemispheric of greater than 90% readings signifying abnormal bihemispheric cerebral physiology. We also showed the cerebral oximetry's functionality in detecting 3% HTS therapeutic effects on SCEDKA's abnormal cerebral physiology and the beneficial therapeutic effects of 3% HTS infusion in SCEDKA patients. Using cerebral oximetry in pediatric DKA patients' initial cerebral assessment could have a significant impact in detecting SCEDKA patients. Further SCEDKA research using cerebral oximetry should be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000001774","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:52:07Z","timestamp":1554684727000},"page":"e511-e518","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Bihemispheric Cerebral Oximetry Monitoring's Functionality in Suspected Cerebral Edema Diabetic Ketoacidosis With Therapeutic 3% Hyperosmolar Therapy in a Pediatric Emergency Department"],"prefix":"10.1097","volume":"38","author":[{"given":"Thomas J.","family":"Abramo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Szlam","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Medicine Associates, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailey","family":"Hargrave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zena Leah","family":"Harris","sequence":"additional","affiliation":[{"name":"Lurie Children's Hospital, Northwestern Feinberg School of Medicine, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby","family":"Williams","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Medicine Associates, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Meredith","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Tennessee, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Hedrick","sequence":"additional","affiliation":[{"name":"Division of Pediatrics Emergency Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuopei","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Biostatistics ACHRI, Department of Pediatrics, Arkansas Children's Hospital Research Institute, College of Medicine, University of Arkansas, Little Rock, AR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Nick","sequence":"additional","affiliation":[{"name":"Division of Biostatistics ACHRI, Department of Pediatrics, Arkansas Children's Hospital Research Institute, College of Medicine, University of Arkansas, Little Rock, AR."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cruz Velasco","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Division of Biostatistics ACHRI, Department of Pediatrics, Arkansas Children's Hospital Research Institute, College of Medicine, University of Arkansas, Little Rock, AR."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"bib1-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1399-543X.2006.00156.x","article-title":"Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis","volume":"7","year":"2006","journal-title":"Pediatr Diabetes"},{"key":"bib2-20250504","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jpeds.2004.12.041","article-title":"Population based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis","volume":"146","year":"2005","journal-title":"J Pediatr"},{"key":"bib3-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/PCC.0b013e31816c7082","article-title":"Cerebral edema in diabetic ketoacidosis","volume":"9","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"bib4-20250504","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1067\/mpd.2002.128888","article-title":"Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema","volume":"141","year":"2002","journal-title":"J Pediatr"},{"key":"bib5-20250504","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM200101253440404","article-title":"Risk factors for cerebral edema in children with diabetic ketoacidosis","volume":"344","year":"2001","journal-title":"N Engl J Med"},{"key":"bib6-20250504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/PCC.0000000000001027","article-title":"Suspected cerebral edema in diabetic ketoacidosis: is there still a role for head CT in treatment decisions?","volume":"18","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"bib7-20250504","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/07435800500451912","article-title":"Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps","volume":"31","year":"2005","journal-title":"Endocr Res"},{"key":"bib8-20250504","first-page":"273","article-title":"An update on cerebral oxygenation monitoring, an innovative application in cardiac arrest and neurological emergencies","year":"2015","journal-title":"Annu Update Intensive Care Emerg Med"},{"key":"bib9-20250504","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajem.2013.10.047","article-title":"Cerebral oxygen saturation monitoring in pediatric altered mental status patients","volume":"32","year":"2014","journal-title":"Am J Emerg Med"},{"key":"bib10-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/PEC.0000000000000141","article-title":"Innovative application of cerebral rSO2 monitoring during shunt tap in pediatric ventricular malfunctioning shunts","volume":"31","year":"2015","journal-title":"Pediatr Emerg Care"},{"key":"bib11-20250504","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ajem.2015.07.037","article-title":"Cerebral oximetry with cerebral blood volume index in detecting pediatric stroke in a pediatric ED","volume":"33","year":"2015","journal-title":"Am J Emerg Med"},{"key":"bib12-20250504","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/01.CCM.0000227182.51591.21","article-title":"Cerebral hyperemia and impaired cerebral autoregulation associated with diabetic ketoacidosis in critically ill children","volume":"34","year":"2006","journal-title":"Crit Care Med"},{"key":"bib13-20250504","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jpeds.2013.06.008","article-title":"Cerebral hyperemia measured with near infrared spectroscopy during treatment of diabetic ketoacidosis in children","volume":"163","year":"2013","journal-title":"J Pediatr"},{"key":"bib14-20250504","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/092986709787002853","article-title":"Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets","volume":"16","year":"2009","journal-title":"Curr Med Chem"},{"key":"bib15-20250504","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF00265021","article-title":"Alterations in erythrocytes in hyperosmolar diabetic decompensation: a pathophysiological basis for impaired blood flow and for an improved design of fluid therapy","volume":"28","year":"1985","journal-title":"Diabetologia"},{"key":"bib16-20250504","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/PCC.0b013e3182975cab","article-title":"Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality","volume":"14","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"bib17-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1399-5448.2001.20409.x","article-title":"Use of hypertonic saline in the treatment of cerebral edema in diabetic ketoacidosis (DKA)","volume":"2","year":"2001","journal-title":"Pediatr Diabetes"},{"key":"bib18-20250504","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.PCC.0000059340.19010.CE","article-title":"Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis","volume":"4","year":"2003","journal-title":"Pediatr Crit Care Med"},{"key":"bib19-20250504","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/2011.7.JNS102142","article-title":"Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis","volume":"116","year":"2012","journal-title":"J Neurosurg"},{"key":"bib20-20250504","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3171\/jns.1963.20.11.0961","article-title":"Effects of infusion of hypertonic mannitol on electrolyte balance and on osmolarity of serum and cerebrospinal fluid","volume":"20","year":"1963","journal-title":"J Neurosurg"},{"key":"bib21-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"key":"bib22-20250504","first-page":"1046","article-title":"Cranial CT in children and adolescents with diabetic ketoacidosis","volume":"9","year":"1988","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib23-20250504","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpeds.2008.04.048","article-title":"Correlation of clinical and biochemical findings with diabetic ketoacidosis-related cerebral edema in children using magnetic resonance diffusion-weighted imaging","volume":"153","year":"2008","journal-title":"J Pediatr"},{"key":"bib24-20250504","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/jcbfm.2012.5","article-title":"Control of brain capillary blood flow","volume":"32","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib25-20250504","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1464-5491.2000.00370.x","article-title":"Serum S-100beta protein is a potential biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis","volume":"17","year":"2000","journal-title":"Diabet Med"},{"key":"bib26-20250504","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.2.6133.325","article-title":"Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity","volume":"2","year":"1978","journal-title":"BMJ"},{"key":"bib27-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1464-5491.1987.tb00865.x","article-title":"Abnormal cerebrovascular carbon dioxide reactivity in people with diabetes","volume":"4","year":"1987","journal-title":"Diabet Med"},{"key":"bib28-20250504","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/pedi.12268","article-title":"Fluid management in pediatric patients with DKA and rates of suspected clinical cerebral edema","volume":"16","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"bib29-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1081\/ERC-200033190","article-title":"Cerebral vasoreactivity in children and adolescents with type 1 diabetes mellitus","volume":"30","year":"2004","journal-title":"Endocr Res"},{"key":"bib30-20250504","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpeds.2004.03.045","article-title":"Mechanism of cerebral edema in children with diabetic ketoacidosis","volume":"145","year":"2004","journal-title":"J Pediatr"},{"key":"bib31-20250504","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2337\/diacare.27.7.1541","article-title":"Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification","volume":"27","year":"2004","journal-title":"Diabetes Care"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T19:02:39Z","timestamp":1746385359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001774","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,4]]}}}